 BEIJING--BUSINESS WIRE--Genetron Holdings Limited Genetron Health or the Company Nasdaq: GTH, a leading precision oncology company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, today announced that its early liver cancer screening research results were cited by the Chinese Anti-Cancer Association Guidelines for Patients with Primary Liver Cancer the Guidelines. The Guidelines, issued by the 